Meanwhile, an increase in counterfeiting and more biological ingredients ramped up the need for more complex monitoring, and more complex supply chains. In the pharmaceutical industry, good distribution requires ensuring that the entire supply chain and distribution network is focused on compliance with regulatory requirements at every point and that the product is fit for use when it reaches the patient. The GDP certification was a major stepping stone in Wallenborn’s ability to confidently service pharma clients.